Investor's Business Daily

AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug

AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug·Investor's Business Daily

ALLISON GATLIN

Mon, Sep 23, 2024, 10:06 PM2 min read

In this article:

AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast cancer.

Continue reading

Advertisement